Pediatric Drugs

期刊简介：Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:-overviews of contentious or emerging issues.-comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.-practical reviews covering optimum drug management of specific clinical situations.-systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.-Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.-original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

【译文】儿科药物促进对儿科药物疗法（包括疫苗）感兴趣的医疗保健专业人员对药物治疗所有方面的优化和进步。该期刊的综述和原创研究文章为医疗保健决策者提供了与新生儿学和儿童及青少年护理中药物疗法相关问题的临床应用知识。该期刊包括：有争议或新兴问题的概述。-关于通过儿科发展的各个阶段有效和安全管理药物疗法的全面叙述性综述。-涵盖特定临床情况最佳药物管理的实用综述。-系统综述，收集经验证据以回答特定研究问题，使用PRISMA声明中概述的明确、系统的方法。-Adis药物综述，包括儿科人群中新型和现有药物的特性和治疗地位。-报告精心设计的研究结果，这些研究具有与临床实践强烈联系的原创新研究文章，例如临床药效学和药代动力学研究、临床试验、荟萃分析、结果研究和药物经济学和药物流行病学研究。此外，与文章一起发布的数字功能（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画）旨在增加期刊内容的可见性、读者群和教育价值。此外，儿科药物上发表的文章可能附有通俗易懂的摘要，以帮助那些对该领域有一定了解但不是深入了解的读者了解重要的医学进展。